Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.51 - $11.75 $45,492 - $118,522
-10,087 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$8.98 - $15.55 $25,467 - $44,099
-2,836 Reduced 21.95%
10,087 $108,000
Q3 2021

Nov 15, 2021

BUY
$14.0 - $16.5 $39,340 - $46,365
2,810 Added 27.79%
12,923 $203,000
Q2 2021

Aug 16, 2021

BUY
$13.03 - $17.0 $131,772 - $171,921
10,113 New
10,113 $145,000

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.